Director Office of CV Devices
U.S. Food and Drug Administration
Silver Spring, Maryland, United States
Dr. Bram Zuckerman is a graduate of the Boston University Medical School. He completed post-graduate training in internal medicine at Baltimore City Hospital and cardiology at the Johns Hopkins program. Prior to joining FDA in 1992, he was involved in basic research in hemodynamics at the University of Colorado Medical School and practiced noninvasive and invasive cardiology in Denver, Colorado and Northern Virginia. He joined the FDA Division of Cardiovascular Devices (DCD) as a Medical Officer in 1992 and has been actively involved in development and review of clinical trials for many new cardiovascular devices. In May 2001 he was appointed a Deputy Director in DCD. He was appointed as Director of the FDA Division of Cardiovascular Devices in September 2002 and in May 2019 became Director of the FDA Office of Cardiovascular Devices.
Saturday, February 25, 2023
7:00 AM – 7:10 AM ET
Disclosure information not submitted.
Saturday, February 25, 2023
10:10 AM – 10:20 AM ET
Disclosure information not submitted.
Saturday, February 25, 2023
10:30 AM – 10:50 AM ET
Disclosure information not submitted.
Saturday, February 25, 2023
12:20 PM – 12:30 PM ET
Disclosure information not submitted.
Saturday, February 25, 2023
3:30 PM – 5:20 PM ET
Disclosure information not submitted.
Saturday, February 25, 2023
4:10 PM – 5:20 PM ET
Disclosure information not submitted.
Monday, February 27, 2023
2:00 PM – 5:05 PM ET
Disclosure(s): No financial relationships to disclose
Monday, February 27, 2023
4:10 PM – 5:05 PM ET
Disclosure(s): No financial relationships to disclose
Monday, February 27, 2023
4:42 PM – 5:05 PM ET
Disclosure(s): No financial relationships to disclose
Monday, February 27, 2023
3:09 PM – 3:17 PM ET
Disclosure(s): No financial relationships to disclose
Monday, February 27, 2023
3:25 PM – 3:30 PM ET
Disclosure(s): No financial relationships to disclose
Monday, February 27, 2023
3:30 PM – 3:45 PM ET
Disclosure(s): No financial relationships to disclose
Tuesday, February 28, 2023
8:00 AM – 1:30 PM ET
Disclosure(s): No financial relationships to disclose
Tuesday, February 28, 2023
9:35 AM – 10:30 AM ET
Disclosure(s): No financial relationships to disclose
Tuesday, February 28, 2023
10:07 AM – 10:30 AM ET
Disclosure(s): No financial relationships to disclose